Sertoli-Leydig cell tumour in a 13-year-old girl

Gynecological Endocrinology

Volumn 27, Issue 2, 2011, Pages 107-109

  Böttcher, Bettina ^a   Hinney, Bernd ^a   Keyser, Johanna ^a   Kühnle, Ingrid ^a   Schweyer, Stefan ^a   Emons, Günter ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Androgens; hirsutism; vagina

Indexed keywords

ADOLESCENT; ANDROBLASTOMA; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HIRSUTISM; HISTOPATHOLOGY; HUMAN; HYPERANDROGENISM; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME;

ADOLESCENT; FEMALE; HIRSUTISM; HUMANS; HYPERANDROGENISM; OVARIAN NEOPLASMS; SERTOLI-LEYDIG CELL TUMOR;

EID: 78651474028     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.495427     Document Type: Article

References (18)

1. awmf guidelines Kommission Ovar der AGO im Auftrag der Deutschen Krebsgesellschaft e. V. und der Deutschen Gesellschaft fü r Gynäkologie und Geburtshilfe, www. http:// www.uni-duesseldorf.de/AWMF (2007).
2. Colombo N, Parma G, Zanagnolo V, Insinga A. Management of ovarian stromal cell tumors. J Clin Oncol 2007;25:2944-2951.
3. Jung SE, Rha SE, Lee JM, Park SY, OH SN, Cho KS, Lee EJ, Byun JY, Hahn ST. CT and MRI findings of sex cordstromal tumor of the ovary. Am J Roentgenol 2005;185:207-215.
4. Moltz L, Schwartz U, Sörensen R, Pickartz H, Hammerstein J. Ovarian and adrenal vein steroids in patients with nonneoplastic hyperandrogenism: selective catheterization findings. Fertil Steril 1984;42:69-75.
5. Nishiyama S, Hirota Y, Udagawa Y, Kato R, Hayakama N, Tukada K. Efficacy of selective venous catherization in localizing a small androgen-producing tumor in ovary. Med Sci Monit 2008;14:CS 9-CS 12.
6. Zhang M, Cheung MK, Shin JY, Kapp DS, Husain A, Teng NN, Berek JS, Osann K, Chan JK. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary - an analysis of 376 women. Gynecol Oncol 2007;104: 396-400.
7. Roth LM, Anderson MC, Govan AD, Langley FA, Gowing NF, Woodcock AS. Sertoli-Leydig cell tumors: a clinicopathologic study of 34 cases. Cancer 1981;48:187-197.
8. Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol 1985;9:543-569.
9. Gershenson DM. Management of early ovarian cancer: germ cell an sex cord-stromal tumors. Gynecol Oncol 1994;55:S62-S72.
10. Rao GG, Skinner E, Gehrig PA, Duska LR, Coleman RL, Schorge JO. Surgical staging of ovarian low malignant potential tumors. Obstet Gynecol 2004;104:261-266.
11. Zanagnolo V, Pasinetti B, Sartori E. Clinical review of 63 cases of sex cord stromal tumors. Eur J Gynecol Oncol 2004;25: 431-438.
12. Brown J, Sood AK, Deavers MT, Milojevic L, Gershenson DM. Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted? Gynecol Oncol 2009;113:86-90.
13. Gershenson DM, Copeland LJ, Kavanagh JJ, Stringer CA, Saul PB, Wharton JT. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol 1987;70:765-769.
14. Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol 1996;87: 527-531.
15. Schwartz PE, Smith JP. Treatment of ovarian stromal tumors. Am J Obstet Gynecol 1976;125:401-411.
16. Brown J, Shvartsman HS, Deavers MT, Ramondetta LM, Burke TW, Munsell MF, Gershenson DM. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol 2005;97:489-496.
17. Emons G, Schally AV. The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers. Hum Reprod 1994;9:1364-1379.
18. Homesley HD, Bundy BN, Hurteau JA. Bleomycin, etoposide and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a gynecologic oncology study group. Gynecol Oncol 1999;72: 131-137.